Grifols SA (GRFS)
7.01
+0.44
(+6.70%)
USD |
NASDAQ |
May 06, 16:00
6.95
-0.06
(-0.86%)
After-Hours: 07:33
Grifols Price to Book Value: 0.739 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 06, 2024 | 0.739 |
| May 03, 2024 | 0.6927 |
| May 02, 2024 | 0.6737 |
| May 01, 2024 | 0.7159 |
| April 30, 2024 | 0.6779 |
| April 29, 2024 | 0.6832 |
| April 26, 2024 | 0.6726 |
| April 25, 2024 | 0.661 |
| April 24, 2024 | 0.6737 |
| April 23, 2024 | 0.6832 |
| April 22, 2024 | 0.6642 |
| April 19, 2024 | 0.6621 |
| April 18, 2024 | 0.6895 |
| April 17, 2024 | 0.6937 |
| April 16, 2024 | 0.7148 |
| April 15, 2024 | 0.6895 |
| April 12, 2024 | 0.6916 |
| April 11, 2024 | 0.7011 |
| April 10, 2024 | 0.7348 |
| April 09, 2024 | 0.757 |
| April 08, 2024 | 0.7686 |
| April 05, 2024 | 0.7475 |
| April 04, 2024 | 0.7232 |
| April 03, 2024 | 0.7264 |
| April 02, 2024 | 0.7148 |
| Date | Value |
|---|---|
| April 01, 2024 | 0.7043 |
| March 28, 2024 | 0.7043 |
| March 27, 2024 | 0.7011 |
| March 26, 2024 | 0.6832 |
| March 25, 2024 | 0.6705 |
| March 22, 2024 | 0.6558 |
| March 21, 2024 | 0.7148 |
| March 20, 2024 | 0.6631 |
| March 19, 2024 | 0.6389 |
| March 18, 2024 | 0.6378 |
| March 15, 2024 | 0.6463 |
| March 14, 2024 | 0.6073 |
| March 13, 2024 | 0.6684 |
| March 12, 2024 | 0.6631 |
| March 11, 2024 | 0.7137 |
| March 08, 2024 | 0.738 |
| March 07, 2024 | 0.5914 |
| March 06, 2024 | 0.5767 |
| March 05, 2024 | 0.6505 |
| March 04, 2024 | 0.699 |
| March 01, 2024 | 0.7443 |
| February 29, 2024 | 0.7918 |
| February 28, 2024 | 0.9847 |
| February 27, 2024 | 0.9805 |
| February 26, 2024 | 0.9794 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5767
Minimum
Mar 06 2024
3.246
Maximum
Feb 21 2020
1.622
Average
1.452
Median
Nov 01 2021
Price to Book Value Benchmarks
| DBV Technologies SA | 0.9218 |
| Adaptimmune Therapeutics PLC | 7.059 |
| Akari Therapeutics PLC | -- |
| Biodexa Pharmaceuticals Plc | 0.8168 |
| NuCana PLC | 0.4326 |
Price to Book Value Related Metrics
| PE Ratio | 22.53 |
| PS Ratio | 0.66 |
| Price | 7.01 |
| Earnings Yield | 4.44% |
| Market Cap | 4.760B |
| Operating PE Ratio | 5.922 |
| Normalized PE Ratio | 32.88 |